This study confirmed previously published findings and demonstrated how this inhibitor might prevent epigenetic issues caused by toxicity produced by DUX4 overexpression in the pathogenesis of FSHD [116]. The gene discussed is DUX4; the disease is Facioscapulohumeral dystrophy.